1. Preface

• 1.1 Report Description and Scope

• 1.2 Study Objectives

• 1.3 Target Audience and Stakeholders

• 1.4 Currency and Units

• 1.5 Limitations and Assumptions

2. Research Methodology

• 2.1 Research Design and Approach

• 2.1.1 Secondary Research Sources

• 2.1.2 Primary Research Sources

• 2.1.3 Key Data from Primary Sources

• 2.1.4 Breakdown of Primary Interviews

• 2.2 Market Size Estimation

• 2.2.1 Bottom-Up Approach

• 2.2.2 Top-Down Approach

• 2.3 Market Breakdown and Data Triangulation

• 2.4 Assumptions for the Research Study

3. Executive Summary

• 3.1 Global Home Infusion Therapy Market Snapshot

• 3.2 Key Demand-Side Trends

• 3.3 Key Supply-Side Trends

• 3.4 Technology and Innovation Roadmap Overview

• 3.5 Key Findings and Strategic Recommendations

4. Market Overview

• 4.1 Introduction

• 4.2 Market Definition and Scope

• 4.3 Market Taxonomy and Coverage

• 4.4 Value Chain Analysis

• 4.5 Supply Chain Analysis

• 4.6 Pricing Analysis

• 4.7 Regulatory and Reimbursement Landscape

• 4.7.1 Medicare and Medicaid Reimbursement Policies (U.S.)

• 4.7.2 European Healthcare Regulatory Framework

• 4.7.3 Asia Pacific Regulatory Environment

• 4.8 Patent Landscape and Innovation Overview

• 4.9 Impact of COVID-19 on the Home Infusion Therapy Market

• 4.10 Key Industry Developments and Milestones

5. Market Dynamics

• 5.1 Key Market Drivers

• 5.1.1 Dramatic Shift Towards Home Medical Care and Patient Preference for Home Settings

• 5.1.2 Rising Prevalence of Chronic Diseases and Growing Geriatric Population

• 5.1.3 Cost-Effectiveness of Home Infusion Therapy Compared to Hospital-Based Care

• 5.1.4 Rising Demand for Home Care Intravenous Drug Infusion Therapy

• 5.1.5 Increasing Adoption of Telemedicine and Remote Patient Monitoring

• 5.1.6 Technological Advancements in Infusion Drug Delivery Devices and Smart Pumps

• 5.2 Market Restraints

• 5.2.1 Limited Reimbursement for Homecare in Developing Nations

• 5.2.2 Lack of Trained Medical Personnel for Home Infusion Services in Emerging Markets

• 5.2.3 Regulatory Complexities Across Geographies

• 5.2.4 Risks of Hospital-Acquired and Catheter-Associated Infections

• 5.3 Market Opportunities

• 5.3.1 Expansion of Home Health Agency Networks and Specialty Pharmacy Collaborations

• 5.3.2 Growing Strategic Collaborations Between Healthcare Providers, Pharma, and Technology Firms

• 5.3.3 Rising Demand for Biologics and Specialty Medications Administered at Home

• 5.3.4 Untapped Potential in Asia Pacific and Latin American Markets

• 5.4 Market Challenges

• 5.4.1 Telehealth-Only Nursing Visits and Limitations in Remote Patient Data Collection

• 5.4.2 Supply Chain Disruptions in Medical Consumables and Drug Delivery Components

• 5.5 Emerging Trends

• 5.5.1 Surge in Adoption of Wearables and Point-of-Care Technology for Infusion Monitoring

• 5.5.2 Increasing Use of AI-Enabled Smart Infusion Pumps with Barcode Verification

• 5.5.3 Growth of Value-Based Care Models Driving Homecare Preference

• 5.5.4 Rise in Subcutaneous Infusion as an Alternative to Intravenous Administration

• 5.5.5 High M&A Activity Among Leading Home Infusion Service Providers

6. Scenario Forecast Analysis

• 6.1 Demand in Optimistic Scenario

• 6.2 Demand in Likely/Base Scenario

• 6.3 Demand in Conservative Scenario

• 6.4 Opportunity Map Analysis

• 6.5 Investment Feasibility Matrix

• 6.6 Product Life Cycle Analysis

7. Strategic Frameworks and Analysis

• 7.1 PESTLE Analysis

• 7.1.1 Political Factors

• 7.1.2 Economic Factors

• 7.1.3 Social Factors

• 7.1.4 Technological Factors

• 7.1.5 Legal and Regulatory Factors

• 7.1.6 Environmental Factors

• 7.2 Porter's Five Forces Analysis

• 7.2.1 Threat of New Entrants

• 7.2.2 Bargaining Power of Buyers

• 7.2.3 Bargaining Power of Suppliers

• 7.2.4 Threat of Substitute Products

• 7.2.5 Intensity of Competitive Rivalry

• 7.3 Global Home Infusion Therapy Market: SWOT Analysis

8. Global Home Infusion Therapy Market Analysis and Forecast, By Type

• 8.1 Introduction and Key Findings

• 8.2 Historical Market Size Analysis, By Type

• 8.3 Market Size Forecast, By Type

• 8.4 Product

• 8.4.1 Infusion Pumps

• 8.4.1.1 Elastomeric Infusion Pumps

• 8.4.1.2 Electromechanical/Smart Infusion Pumps

• 8.4.1.3 Gravity Infusion Pumps

• 8.4.1.4 Ambulatory Infusion Pumps

• 8.4.1.5 Others

• 8.4.2 Intravenous (IV) Sets

• 8.4.3 IV Cannulas

• 8.4.4 Needleless Connectors

• 8.4.4.1 Fastest Growing Sub-Segment: Reducing Needlestick Injuries and Improving Safety

• 8.5 Services

• 8.5.1 Services Segment Dominance: 72.4% Revenue Share Due to Chronic Disease Burden and Skilled Nursing Demand

• 8.5.2 Market Size and Forecast

• 8.6 Y-o-Y Growth Trend Analysis, By Type

• 8.7 Absolute $ Opportunity Analysis, By Type

9. Global Home Infusion Therapy Market Analysis and Forecast, By Product (Drugs, Devices & Services)

• 9.1 Introduction and Key Findings

• 9.2 Historical Market Size Analysis, By Product

• 9.3 Market Size Forecast, By Product

• 9.4 Drugs

• 9.4.1 Drugs Segment Dominance: Robust Pipeline of Injectable and Biologic Therapeutics

• 9.4.2 Market Size and Forecast

• 9.5 Devices

• 9.5.1 Growing Innovation in Portable and Smart Medication Delivery Systems

• 9.5.2 Market Size and Forecast

• 9.6 Services

• 9.6.1 Rise in Healthcare Professional Training and Home Infusion Service Delivery Networks

• 9.6.2 Market Size and Forecast

• 9.7 Y-o-Y Growth Trend Analysis, By Product

• 9.8 Absolute $ Opportunity Analysis, By Product

10. Global Home Infusion Therapy Market Analysis and Forecast, By Application/Indication

• 10.1 Introduction and Key Findings

• 10.2 Historical Market Size Analysis, By Application

• 10.3 Market Size Forecast, By Application

• 10.4 Anti-Infective

• 10.4.1 Dominance Due to High Volume of Antibiotic and Antifungal Drug Administration

• 10.4.2 Market Size and Forecast

• 10.5 Chemotherapy

• 10.5.1 Fastest Growing Segment: Rising Cancer Incidence and Compact Pump Availability

• 10.5.2 Market Size and Forecast

• 10.6 Hydration Therapy

• 10.6.1 Athlete and General Population Sub-Segments

• 10.6.2 Market Size and Forecast

• 10.7 Enteral Nutrition

• 10.7.1 Market Size and Forecast

• 10.8 Total Parenteral Nutrition (TPN)

• 10.8.1 Growing Use in Gastrointestinal Disorder and Critical Care Patients

• 10.8.2 Market Size and Forecast

• 10.9 Intravenous Immunoglobulin (IVIG) Therapy

• 10.9.1 Rising Prevalence of Primary Immunodeficiency Diseases Driving Demand

• 10.9.2 Market Size and Forecast

• 10.10 Endocrinology

• 10.10.1 Diabetes Sub-Segment

• 10.10.2 Others

• 10.11 Specialty Pharmaceuticals

• 10.12 Pain Management

• 10.13 Others

• 10.14 Y-o-Y Growth Trend Analysis, By Application

• 10.15 Absolute $ Opportunity Analysis, By Application

11. Global Home Infusion Therapy Market Analysis and Forecast, By Region

• 11.1 Introduction

• 11.2 Historical Market Size Analysis, By Region

• 11.3 Market Size Forecast, By Region

• 11.3.1 North America

• 11.3.2 Europe

• 11.3.3 Asia Pacific

• 11.3.4 Latin America

• 11.3.5 Middle East & Africa

• 11.4 Market Attractiveness Analysis, By Region

12. North America Home Infusion Therapy Market Analysis and Forecast

• 12.1 Introduction and Key Findings

• 12.2 Historical Market Size Trend Analysis, By Market Taxonomy

• 12.3 Market Size Forecast, By Market Taxonomy

• 12.3.1 By Country: United States, Canada, Mexico

• 12.3.2 By Type

• 12.3.3 By Product

• 12.3.4 By Application/Indication

• 12.4 United States

• 12.4.1 North America Dominates with 41.20–56.6% Revenue Share Owing to Strong Home Health Agency Network and Favorable Medicare/Medicaid Reimbursement

• 12.4.2 Growing Adoption of Alternate Healthcare and Home Infusion Services

• 12.4.3 Pricing Analysis

• 12.4.4 Market Share Analysis

• 12.5 Canada

• 12.5.1 Rising Geriatric Population and Shift from Acute Care to Home Care Settings

• 12.6 Mexico

• 12.6.1 Emerging Awareness and Adoption of Home Infusion Services

• 12.7 Market Attractiveness Analysis, By Country

• 12.8 Key Takeaways

13. Europe Home Infusion Therapy Market Analysis and Forecast

• 13.1 Introduction and Key Findings

• 13.2 Historical Market Size Trend Analysis, By Market Taxonomy

• 13.3 Market Size Forecast, By Market Taxonomy

• 13.3.1 By Country: Germany, UK, France, Italy, Spain, Netherlands, Belgium, Switzerland, Russia, Sweden, Rest of Europe

• 13.3.2 By Type

• 13.3.3 By Product

• 13.3.4 By Application/Indication

• 13.4 Germany — Strong Reimbursement Policies and Healthcare Infrastructure Supporting Growth

• 13.5 United Kingdom — NHS Collaboration and Advanced Infusion Pump Adoption

• 13.6 France — Government and Market Player Initiatives Toward Home-Based Infusion Care

• 13.7 Italy

• 13.8 Spain

• 13.9 Netherlands

• 13.10 Belgium

• 13.11 Switzerland

• 13.12 Russia

• 13.13 Sweden

• 13.14 Rest of Europe

• 13.15 Market Attractiveness Analysis, By Country

• 13.16 Key Takeaways

14. Asia Pacific Home Infusion Therapy Market Analysis and Forecast

• 14.1 Introduction and Key Findings

• 14.2 Historical Market Size Trend Analysis, By Market Taxonomy

• 14.3 Market Size Forecast, By Market Taxonomy

• 14.3.1 By Country: China, Japan, India, South Korea, Australia, Indonesia, Malaysia, Singapore, Thailand, Philippines, Rest of APAC

• 14.3.2 By Type

• 14.3.3 By Product

• 14.3.4 By Application/Indication

• 14.4 China — Rising Chronic Disease Prevalence, Aging Population, and Home-Based Care Shift

• 14.5 Japan — Aging Population and High Preference for Home-Based Care with Advanced Portable Device Adoption

• 14.6 India — Rising Awareness of Home Infusion Benefits and Government NP-NCD Initiatives

• 14.7 South Korea

• 14.8 Australia

• 14.9 Indonesia

• 14.10 Malaysia

• 14.11 Singapore

• 14.12 Thailand

• 14.13 Philippines

• 14.14 Rest of Asia Pacific

• 14.15 Market Attractiveness Analysis, By Country

• 14.16 Key Takeaways

15. Latin America Home Infusion Therapy Market Analysis and Forecast

• 15.1 Introduction and Key Findings

• 15.2 Historical Market Size Trend Analysis, By Market Taxonomy

• 15.3 Market Size Forecast, By Market Taxonomy

• 15.3.1 By Country: Brazil, Argentina, Colombia, Chile, Rest of Latin America

• 15.3.2 By Type

• 15.3.3 By Product

• 15.3.4 By Application/Indication

• 15.4 Brazil

• 15.5 Argentina

• 15.6 Colombia

• 15.7 Chile

• 15.8 Rest of Latin America

• 15.9 Market Attractiveness Analysis, By Country

• 15.10 Key Takeaways

16. Middle East & Africa Home Infusion Therapy Market Analysis and Forecast

• 16.1 Introduction and Key Findings

• 16.2 Historical Market Size Trend Analysis, By Market Taxonomy

• 16.3 Market Size Forecast, By Market Taxonomy

• 16.3.1 By Country: Saudi Arabia, UAE, South Africa, Israel, Egypt, Rest of MEA

• 16.3.2 By Type

• 16.3.3 By Product

• 16.3.4 By Application/Indication

• 16.4 Saudi Arabia

• 16.5 UAE

• 16.6 South Africa

• 16.7 Israel

• 16.8 Egypt

• 16.9 Rest of Middle East & Africa

• 16.10 Market Attractiveness Analysis, By Country

• 16.11 Key Takeaways

17. Competitive Landscape

• 17.1 Overview

• 17.2 Market Ranking Analysis

• 17.3 Market Share Analysis of Top Players

• 17.3.1 By Region

• 17.3.2 By Type

• 17.3.3 By Product

• 17.3.4 By Application/Indication

• 17.4 Competitive Benchmarking Dashboard

• 17.5 Competitive Situations and Trends

• 17.5.1 Product Launches and Innovations

• 17.5.2 Agreements, Partnerships, and Collaborations

• 17.5.3 Mergers and Acquisitions

• 17.5.4 Geographic Expansions and Capacity Investments

• 17.6 Key Strategies Adopted by Leading Players

• 17.6.1 Development of Innovative Infusion Pumps and Smart Drug Delivery Devices

• 17.6.2 Specialty Pharmacy Network Expansion and Hospital Collaboration Strategy

• 17.6.3 Telehealth and Remote Patient Monitoring Integration

• 17.6.4 Strategic M&A to Consolidate and Expand Product and Service Portfolios

18. Company Profiles

The final report includes a complete list of companies

• 18.1 Option Care Health, Inc.

  • 18.1.1 Company Overview

  • 18.1.2 Financial Performance

  • 18.1.3 Product Portfolio

  • 18.1.4 Strategic Initiatives

  • 18.1.5 SWOT Analysis

• 18.2 Baxter International Inc.

• 18.3 B. Braun SE

• 18.4 Fresenius Kabi AG

• 18.5 ICU Medical, Inc.

• 18.6 Optum, Inc. (UnitedHealth Group)

• 18.7 CVS Health / Coram LLC

• 18.8 CareCentrix, Inc.

• 18.9 Becton, Dickinson and Company (BD)

• 18.10 Terumo Corporation

• 18.11 PharMerica Corporation

• 18.12 Moog Inc.

• 18.13 Amedisys, Inc.

• 18.14 InfuSystem Holdings, Inc.

• 18.15 KabaFusion

19. Assumptions and Acronyms Used

20. Research Methodology — Detailed Appendix

• 20.1 Insights from Industry Experts

• 20.2 Discussion Guide

• 20.3 List of Secondary Sources and References

• 20.4 Available Customizations

• 20.5 Related Market Reports

21. Disclaimer